Keywords: آدریانامین; Carboxymethyl chitosan oligosaccharide; Adriamycin; Glomerulosclerosis; Tubulointerstitial fibrosis; Oxidative stress;
مقالات ISI آدریانامین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آدریانامین; Doxorubicin; Adriamycin; Cardiotoxicity; Signalling mechanism; Oxidative stress;
Keywords: آدریانامین; Adriamycin; Cardiotoxicity; Captopril; Carvedilol;
Keywords: آدریانامین; Testes; Treadmill exercise; Adriamycin; Protein oxidation; Proteomics;
Keywords: آدریانامین; Cardiomyopathy; Diabetes; Animal model for cardiomyopathy; Adriamycin; Diabetic cardiomyopathy;
Keywords: آدریانامین; ADR; Adriamycin; BD; Brownian dynamics; CG; Coarse-grained; CMC; Critical micelle concentration; CUDA; Compute unified device architecture; DDFT; Dynamic density functional theory; DFT; Density functional theory; DLS; Dynamic light scattering; DMFT; Dynam
Keywords: آدریانامین; Adr; Adriamycin; miRNA; microRNA; MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; mRNA; messenger RNA; RT-qPCR; real-time quantitative PCR; KEGG; Kyoto Encyclopedia of Genes and Genomes; PPI; protein-protein interaction; CHOL; cholest
Keywords: آدریانامین; adriamycin; caspase-3; proliferating cell nuclear antigen; rats; renal cortex; stem cells;
Keywords: آدریانامین; Adriamycin; Exercise; Brain bioenergetics; Apoptosis; Mitochondrial dynamics; Autophagy signaling;
Keywords: آدریانامین; Childhood cancer; Adriamycin; Breast cancer; Trastuzumab; Autonomic dysfunction; Hypothermia;
Keywords: آدریانامین; LC, liver cystatin; ADR, adriamycin; CD, circular dichroism; Ka, binding constant; HBV, human hepatitis B virusLiver cystatin; Adriamycin; Adevofir dipivoxil; Fluorescence; UV-spectroscopy
Keywords: آدریانامین; Furosemide; Captopril; Isoproterenol; Angiotensin II; Plasma renin activity; Vasopressin; Aldosterone; Adriamycin;
Keywords: آدریانامین; Adriamycin; Metformin; Transplantable tumor; Mice
Keywords: آدریانامین; liposomes; stealth liposomes; drug delivery systems; superhydrophilic polymer; persistence circulation; Adriamycin; pharmacokinetics; polymers; zwitterion;
Keywords: آدریانامین; Cardioprotection; Adriamycin; Exercise; Bioenergetics; Oxidative damage;
Keywords: آدریانامین; Betulonic acid derivatives; Synthesis; Antitumor; Apoptosis; Mitochondrial pathway; ADM; adriamycin; AO/EB; acridine orange/ethidium bromide; BetA; betulonic acid; 13C NMR; 13C Nuclear Magnetic Resonance; DMF; N, N-dimethylformamide; DMSO; dimethyl sulfox
Keywords: آدریانامین; ABEI; N-(4-aminobutyl)-N-ethylisoluminol; Ab; Antibody; ADM; Adriamycin; AFP; Alpha fetoprotein; Ag; Antigen; ALP; Alkaline phosphatase; ATP; Adenosine triphosphate; bbc-DL-DNA; bio-bar-code dendrimer-like DNA; BPE; Biophoton emission; CA; Carcinoma antig
Keywords: آدریانامین; Zebrafish; Heart; Ventricle; Contraction; Force; Adriamycin;
Keywords: آدریانامین; ADR; adriamycin; BCNU; carmustine; ACA; aminocinnamic acid; CHL; chlorambucil or para-[N,N-bis(2-chloroethyl)amino]phenylbutyric acid; CNC; chloronitrocarbamoyl; CP; cisplatin; DTIC; dacarbazine; DnsEM; dansyl estramustine; EM; estramustine; EMP; estramus
Keywords: آدریانامین; MiR-367; Osteosarcoma; Adriamycin; KLF4; Apoptosis; Chemotherapy resistance
Knockdown of HuR represses osteosarcoma cells migration, invasion and stemness through inhibition of YAP activation and increases susceptibility to chemotherapeutic agents
Keywords: آدریانامین; HuR; YAP; Osteosarcoma; Adriamycin; Epithelial-mesenchymal transition;
Chronic adriamycin treatment impairs CGRP-mediated functions of meningeal sensory nerves
Keywords: آدریانامین; Adriamycin; Calcitonin gene-related peptide; Transient receptor potential vanilloid 1; Transient receptor potential ankyrin 1; Dura mater; Meningeal blood flow;
4-Hydroxybenzoic acid (4-HBA) enhances the sensitivity of human breast cancer cells to adriamycin as a specific HDAC6 inhibitor by promoting HIPK2/p53 pathway
Keywords: آدریانامین; Breast cancer; Adriamycin; 4-Hydroxybenzoic acid; HIPK2/p53; HDAC6;
Tanshinone IIA inhibits cervix carcinoma stem cells migration and invasion via inhibiting YAP transcriptional activity
Keywords: آدریانامین; HuR; YAP; Cervix carcinoma; Stemness; Adriamycin;
Nitric oxide reverses drug resistance by inhibiting ATPase activity of p-glycoprotein in human multi-drug resistant cancer cells
Keywords: آدریانامین; Nitric Oxide; Multi-drug resistance; P-gp protein; Adriamycin; Taxol; Free radical; P-gp; P-glycoprotein 170; MDR; multi-drug resistance; ADR; Adriamycin; TX; taxol; ËNO; nitric oxide; topo; topoisomerase; PPNO; propylamine nonoate; DETNO; diethylenetria
l-Theanine: An astounding sui generis integrant in tea
Keywords: آدریانامین; AIDA; alanine decarboxylase; ALT; alanine transaminase; 5â²-AMP; adenosine monophosphate; L-Th; l-theanine; ADHD; attention deficit hyperactivity disorder; ADA; adriamycin; AD; Alzheimer disease; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic aci
ETV7-Mediated DNAJC15 Repression Leads to Doxorubicin Resistance in Breast Cancer Cells
Keywords: آدریانامین; ETV7; Ets Variant Gene 7; ETS; E26 Transformation-Specific; DNAJC15; DNAJ Heat Shock Protein family (Hsp40) member C15; ABCB1; ATP Binding Cassette subfamily B member 1; DNMT3A; DNA Methyl-Transferase 3A; 5-Aza; 5-Aza-2â²-deoxycytidine; TNBC; Triple Nega
The CD44 variant induces K562 cell acquired with resistance to adriamycin via NF-κB/Snail/Bcl-2 pathway
Keywords: آدریانامین; CD44v16; Drug resistance; Adriamycin; K562;
Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562/ADM cells by suppressing MDR1 gene/P-glycoprotein expression
Keywords: آدریانامین; Multidrug resistance; Chronic myelogenous leukemia; Germacrone; Adriamycin; MDR1; P-glycoprotein;
High-mobility group box 1 protein-mediated necroptosis contributes to dasatinib-induced cardiotoxicity
Keywords: آدریانامین; HMGB1; high mobility group box 1; CML; chronic myelogenous leukemia; Ph+ALL; Philadelphia chromosome positive acute lymphoblastic leukemia; RIP1; receptor-interacting protein kinase 1; RIP3; receptor-interacting protein kinase 3; MLKL; mixed lineage kinas
O2-(2,4-dinitrophenyl)diazeniumdiolates derivatives: Design, synthesis, cytotoxic evaluation and reversing MDR in MCF-7/ADR cells
Keywords: آدریانامین; Diazeniumdiolates; No-Releasing; JS-K; Adriamycin; Multidrug resistance;
Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer
Keywords: آدریانامین; GSTP1; glutathione S-transferase P1; PD; progressive disease; SD; stable disease; PR; partial response; CR; complete response; TSG101; tumour susceptibility gene 101 protein; BCa; breast cancer; microRNA; miRNA; DNA; deoxyribonucleic acid; HSP70; heat sho
Ameliorative effects of sildenafil and/or febuxostat on doxorubicin-induced nephrotoxicity in rats
Keywords: آدریانامین; Doxorubicin; Adriamycin; (PubChem CID: 31703); Sildenafil citrate (PubChem CID: 62853); Febuxostat (PubChem CID: 134018); Nephrotoxicity; Doxorubicin; Sildenafil; Febuxostat; Oxidative stress; Antiinflammatory;
MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway
Keywords: آدریانامین; ADR; adriamycin; miRNA; microRNA; UTR; untranslated region; PTEN; phosphatase a tensin homolog deleted on chromosome 10; PIP3; phosphatidylinositol-3,4,5-triphosphate; PIP2; diphosphate product; IC50; the inhibitory concentration to produce 50% cell death
Glycyrrhizic acid: A promising carrier material for anticancer therapy
Keywords: آدریانامین; ACF; aberrant crypt foci; ADR; adriamycin; AKT; serine-threonine protein kinase; ALK; anaplastic lymphoma kinase; ALP; alkaline phosphatase; ALT; alanine aminotransferase; AST; serum levels of aspartate aminotransferase; A549; lung adenocarcinoma cell lin
Paeoniflorin ameliorates Adriamycin-induced nephrotic syndrome through the PPARγ/ANGPTL4 pathway in vivo and vitro
Keywords: آدریانامین; PF; paeoniflorin; NS; nephrotic syndrome; ADR; adriamycin; PPARγ; peroxisome proliferator-activated receptor gamma; ANGPTL4; angiopointin-like 4; HE; hematoxylin-eosin; Scr; Serum creatinine; TG; triglycerides; TP; serum total protein; ALB; serum albumin
Downregulation of TIGAR sensitizes the antitumor effect of physapubenolide through increasing intracellular ROS levels to trigger apoptosis and autophagosome formation in human breast carcinoma cells
Keywords: آدریانامین; PB; physapubenolide; ROS; reactive oxygen species; TIGAR; TP53-induced glycolysis and apoptosis regulator; NAC; N-acetylcysteine; PCD; programmed cell death; ADR; Adriamycin; MDA; Malondialdehyde; AO; acridine orange; Physapubenolide; Apoptosis; Autophagy
Effects of a novel photoactivated photosensitizer on MDR1 over-expressing human breast cancer cells
Keywords: آدریانامین; Adriamycin; Multidrug resistance; DTP; Photodynamic therapy; MDR1 gene; P-glycoprotein;
Design, synthesis and biological evaluation of 4-anilinoquinoline derivatives as novel potent tubulin depolymerization agents
Keywords: آدریانامین; Quinoline; Antiproliferative; Microtubules; Depolymerization; Antimitotic; EBI; N, Nâ²-ethylenebis (iodoacetamide); CA-4; combretastatin A-4; FDA; Food and Drug Administration; EMA; European Medicines Agency; DMF; N, N-Dimethylformamide; MTT; 3-(4,5-dime
MiR-509-3-5p causes aberrant mitosis and anti-proliferative effect by suppression of PLK1 in human lung cancer A549 cells
Keywords: آدریانامین; miR-509-3-5p; PLK1; Aberrant mitosis; Cisplatin; Adriamycin; DNA damage response;
miR-222 confers the resistance of breast cancer cells to Adriamycin through suppression of p27kip1 expression
Keywords: آدریانامین; Adr, Adriamycin; microRNA, miRNA; Bak1, Bcl-2 Antagonist Killer 1; 3ʹUTR, 3′-untranslation region; SOCS1, suppressor of cytokine signaling 1; CDKN1B, cyclin-dependent kinase inhibit 1BmiR-222; Adriamycin; Drug resistance; p27kip1; Breast cancer
Downregulation of miR-221 enhances the sensitivity of human oral squamous cell carcinoma cells to Adriamycin through upregulation of TIMP3 expression
Keywords: آدریانامین; miR-221; Oral squamous cell carcinoma; Adriamycin; TIMP3
Histological study on the protective effect of endogenous stem-cell mobilization in Adriamycin-induced chronic nephropathy in rats
Keywords: آدریانامین; adriamycin; caspase-3; CD34; chronic kidney disease; granulocyte colony-stimulating factor
Inhibition of autophagy promotes apoptosis and enhances anticancer efficacy of adriamycin via augmented ROS generation in prostate cancer cells
Keywords: آدریانامین; ADM; adriamycin; ADT; androgen deprivation therapies; CQ; chloroquine; CRPA; castration-resistant prostate cancer; DCFH-DA; 2â²,7â²-dichlorofluorescein diacetate; DMEM; Dulbecco's modified Eagle's medium; DMSO; dimethyl sulfoxide; FBS; fetal bovine seru
An ultrasensitive electrochemical DNA biosensor based on a copper oxide nanowires/single-walled carbon nanotubes nanocomposite
Keywords: آدریانامین; Electrochemical; CuO nanowire; Single-walled carbon nanotube; Adriamycin; Differential pulse voltammetry; DNA biosensor;
LC-MS/MS method for simultaneous determination of thalidomide, lenalidomide, cyclophosphamide, bortezomib, dexamethasone and adriamycin in serum of multiple myeloma patients
Keywords: آدریانامین; MM; multiple myeloma; SEER; surveillance epidemiology and end results; BTZ; bortezomib; CTX; cyclophosphamide; ADM; adriamycin; LND; lenalidomide; THD; thalidomide; MEL; melphalan; DXM; dexamethasone; PDN; prednisone; LC-MS/MS; high performance liquid c
Synthesis and in vitro antitumor evaluation of betulin acid ester derivatives as novel apoptosis inducers
Keywords: آدریانامین; Betulin derivatives; Synthesis; Antitumor; Cancer cells; Apoptosis; ADM; adriamycin; AO/EB; acridine orange/ethidium bromide; BE; betulin; 13C NMR; 13C nuclear magnetic resonance; DMF; N, N-dimethylformamide; DMSO; dimethyl sulfoxide; HCPT; 10-hydroxyl ca
Down-regulation of Wt1 activates Wnt/β-catenin signaling through modulating endocytic route of LRP6 in podocyte dysfunction in vitro
Keywords: آدریانامین; CKD; Chronic kidney disease; LRP; Low density lipoprotein receptor-related protein; Axin; Axis inhibition protein; APC; Adenomatosis polyposis coli; GSK-3β; Glycogen synthase kinase-3β; TCF/LEF; T-cell factor/lymphocyte enhancer factor; Wt1; Wilms' tumo
MiR-193a-3p promotes the multi-chemoresistance of bladder cancer by targeting the HOXC9 gene
Keywords: آدریانامین; BCa; bladder cancer; MiR; microRNA; HCC; hepatocellular cancer; Pi; pirarubicin; Pa; paclitaxel; Ad; adriamycin; EH; epirubicin hydrochloride; Ci; cisplatin; 5-FU; 5-fluorouracil; UTR; untranslated region; HOXC9; homeobox C9; TERT; telomerase reverse tran
Ginsenoside Rg3 antagonizes adriamycin-induced cardiotoxicity by improving endothelial dysfunction from oxidative stress via upregulating the Nrf2-ARE pathway through the activation of akt
Keywords: آدریانامین; Ginsenoside Rg3; Adriamycin; Cardiotoxicity; Oxidative stress; Nrf2; Aortic ring; ADM; adriamycin; AKT; protein kinase B; Bax; Bcl-2 associated X protein; Bcl-2; B cell lymphoma-2; CMEC; cardiac microvascular endothelial cells; eNOS; endothelial nitric ox